1
|
Wang B, Moyano A, Duque JM, Sánchez L, García-Santos G, Flórez LJG, Serrano-Pertierra E, Blanco-López MDC. Nanozyme-Based Lateral Flow Immunoassay (LFIA) for Extracellular Vesicle Detection. BIOSENSORS 2022; 12:bios12070490. [PMID: 35884293 PMCID: PMC9313400 DOI: 10.3390/bios12070490] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Revised: 07/01/2022] [Accepted: 07/04/2022] [Indexed: 11/26/2022]
Abstract
Extracellular vesicles (EVs) are biological nanoparticles of great interest as novel sources of biomarkers and as drug delivery systems for personalized therapies. The research in the field and clinical applications require rapid quantification. In this study, we have developed a novel lateral flow immunoassay (LFIA) system based on Fe3O4 nanozymes for extracellular vesicle (EV) detection. Iron oxide superparamagnetic nanoparticles (Fe3O4 MNPs) have been reported as peroxidase-like mimetic systems and competent colorimetric labels. The peroxidase-like capabilities of MNPs coated with fatty acids of different chain lengths (oleic acid, myristic acid, and lauric acid) were evaluated in solution with H2O2 and 3,3,5,5-tetramethylbenzidine (TMB) as well as on strips by biotin–neutravidin affinity assay. As a result, MNPs coated with oleic acid were applied as colorimetric labels and applied to detect plasma-derived EVs in LFIAs via their nanozyme effects. The visual signals of test lines were significantly enhanced, and the limit of detection (LOD) was reduced from 5.73 × 107 EVs/μL to 2.49 × 107 EVs/μL. Our work demonstrated the potential of these MNPs as reporter labels and as nanozyme probes for the development of a simple tool to detect EVs, which have proven to be useful biomarkers in a wide variety of diseases.
Collapse
Affiliation(s)
- Baihui Wang
- Department of Physical and Analytical Chemistry, Institute of Biotechnology of Asturias, University of Oviedo, c/Julián Clavería 8, 33006 Oviedo, Spain; (B.W.); (A.M.)
| | - Amanda Moyano
- Department of Physical and Analytical Chemistry, Institute of Biotechnology of Asturias, University of Oviedo, c/Julián Clavería 8, 33006 Oviedo, Spain; (B.W.); (A.M.)
| | - José María Duque
- Hospital Universitario San Agustín, 33401 Avilés, Spain; (J.M.D.); (L.S.)
- Department of Medicine, University of Oviedo, 33006 Oviedo, Spain
| | - Luis Sánchez
- Hospital Universitario San Agustín, 33401 Avilés, Spain; (J.M.D.); (L.S.)
| | - Guillermo García-Santos
- Department of General and Digestive Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain; (G.G.-S.); (L.J.G.F.)
| | - Luis J. García Flórez
- Department of General and Digestive Surgery, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain; (G.G.-S.); (L.J.G.F.)
- Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain
- Department of Surgery, University of Oviedo, 33006 Oviedo, Spain
| | - Esther Serrano-Pertierra
- Department of Physical and Analytical Chemistry, Institute of Biotechnology of Asturias, University of Oviedo, c/Julián Clavería 8, 33006 Oviedo, Spain; (B.W.); (A.M.)
- Correspondence: (E.S.-P.); (M.d.C.B.-L.)
| | - María del Carmen Blanco-López
- Department of Physical and Analytical Chemistry, Institute of Biotechnology of Asturias, University of Oviedo, c/Julián Clavería 8, 33006 Oviedo, Spain; (B.W.); (A.M.)
- Correspondence: (E.S.-P.); (M.d.C.B.-L.)
| |
Collapse
|
2
|
Wen J, Moloney EB, Canning A, Donohoe E, Ritter T, Wang J, Xiang D, Wu J, Li Y. Synthesized nanoparticles, biomimetic nanoparticles and extracellular vesicles for treatment of autoimmune disease: Comparison and prospect. Pharmacol Res 2021; 172:105833. [PMID: 34418563 DOI: 10.1016/j.phrs.2021.105833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2021] [Revised: 08/13/2021] [Accepted: 08/16/2021] [Indexed: 11/18/2022]
Abstract
An emerging strategy is needed to treat autoimmune diseases, many of which are chronic with no definitive cure. Current treatments only alleviate symptoms and have many side effects affecting patient quality of life. Recently, nanoparticle drug delivery systems, an emerging method in medicine, has been used to target cells or organs, without damaging normal tissue. This approach has led to fewer side effects, along with a strong immunosuppressive capacity. Therefore, a nanotechnology approach may help to improve the treatment of autoimmune diseases. In this review, we separated nanoparticles into three categories: synthesized nanoparticles, biomimetic nanoparticles, and extracellular vesicles. This review firstly compares the typical mechanism of action of these three nanoparticle categories respectively in terms of active targeting, camouflage effect, and similarity to parent cells. Then their immunomodulation properties are discussed. Finally, the challenges faced by all these nanoparticles are described.
Collapse
Affiliation(s)
- Jing Wen
- Department of Pharmacy, the Third Hospital of Changsha, Changsha, China
| | - Elizabeth B Moloney
- Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Aoife Canning
- Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Ellen Donohoe
- Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Thomas Ritter
- Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Jiemin Wang
- Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
| | - Daxiong Xiang
- Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China
| | - Junyong Wu
- Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China
| | - Yongjiang Li
- Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China
| |
Collapse
|
3
|
Casciaro B, Mangoni ML. Nanotechnologies to Improve the Pharmacological Profile of Therapeutic Peptides. Curr Protein Pept Sci 2020; 21:332-333. [DOI: 10.2174/138920372104200320110232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Bruno Casciaro
- Center For Life Nano Science@Sapienza Istituto Italiano di Tecnologia Viale Regina Elena 291, 00161 Rome, Italy
| | - Maria Luisa Mangoni
- Department of Biochemical Sciences “A. Rossi Fanelli” Sapienza University of Rome Piazzale Aldo Moro, 5 00185 Roma, Italy
| |
Collapse
|